Members of the Esophageal Adenocarcinoma Study Group Europe (EACSGE) 2022, ' Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models ', Cellular Oncology, vol. 45, no. 4, pp. 639-658 . https://doi.org/10.1007/s13402-022-00689-2 Cellular Oncology, 45(4), 639-658. IOS Press Cellular Oncology (2211-3428) Cellular oncology, 45(4), 639-658. IOS Press